CAPANNI, Marusca

CAPANNI, Marusca  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
Cellular therapy: exploiting NK cell alloreactivity in transplantation 1-gen-2001 Ruggeri, Loredana; Capanni, Marusca; Martelli, Massimo Fabrizio; Velardi, Andrea
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 1-gen-2007 Ruggeri, Loredana; Mancusi, Antonella; Capanni, Marusca; Urbani, Elena; Carotti, A; Aloisi, T; Stern, M; Pende, D; Perruccio, Katia; Burchielli, Emanuela; Topini, F; Bianchi, E; Aversa, Franco; Martelli, Massimo Fabrizio; Velardi, Andrea
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 1-gen-2002 Ruggeri, Loredana; Capanni, Marusca; Urbani, Elena; Perruccio, Katia; Shlomchik, W.; Tosti, A.; Rogaia, D.; Posati, S.; Frassoni, F.; Aversa, Franco; Martelli, Massimo Fabrizio; Velardi, Andrea
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 1-gen-2011 DE ANGELIS, Claudia; Mancusi, Antonella; Ruggeri, Loredana; Capanni, Marusca; Urbani, Elena; Velardi, Andrea; Stern, M.
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 1-gen-1999 Volpi, I.; Perruccio, Katia; Ruggeri, Loredana; Tosti, A.; Capanni, Marusca; Aversa, F.; Tabilio, Antonio; Martelli, Massimo Fabrizio; Velardi, Andrea
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 1-gen-2000 Volpi, I.; Perruccio, Katia; Ruggeri, Loredana; Tosti, A.; Capanni, Marusca; Aversa, F.; Tabilio, Antonio; Martelli, Massimo Fabrizio; Velardi, Andrea
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 1-gen-2008 Stern, M; Ruggeri, Loredana; Capanni, Marusca; Mancusi, Antonella; Velardi, Andrea
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 1-gen-2004 Velardi, Andrea; Ruggeri, Loredana; Capanni, Marusca; Mancusi, Antonella; Perruccio, Katia; Aversa, Franco; Martelli, Massimo Fabrizio
Innate immunity against hematological malignancies 1-gen-2002 Ruggeri, Loredana; Capanni, Marusca; Tosti, A.; Urbani, Elena; Posati, S.; Aversa, F.; Martelli, Massimo Fabrizio; Velardi, Andrea
Natural killer cells as a therapeutic tool in mismatched transplantation 1-gen-2004 Ruggeri, Loredana; Capanni, Marusca; Mancusi, Antonella; Aversa, Franco; Martelli, Massimo Fabrizio; Velardi, Andrea
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 1-gen-2009 Lakshmikanth, T; Burke, S; Ali, Th; Kimpfler, S; Ursini, F; Ruggeri, Loredana; Capanni, Marusca; Umansky, V; Paschen, A; Sucker, A; Pende, D; Groh, V; Biassoni, R; Hoglund, P; Kato, M; Shibuya, K; Schadendorf, D; Anichini, A; Ferrone, S; Velardi, Andrea; Karre, K; Shibuya, A; Carbone, E; Colucci, F.
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 1-gen-2009 Romagne', F; Andre'P, ; Spee, P; Zahn, S; Anfossi, N; Gauthier, L; Capanni, Marusca; Ruggeri, Loredana; BENSON DM, Jr; Blaser, Bw; DELLA CHIESA, M; Moretta, A; Vivier, E; Caligiuri, Ma; Velardi, Andrea; Wagtmann, N.
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 1-gen-2002 Ruggeri, Loredana; Capanni, Marusca; Urbani, Elena; Tosti, A.; Perruccio, Katia; Posati, S.; Aversa, F.; Tabilio, Antonio; Martelli, Massimo Fabrizio; Velardi, Andrea